Saturday, May 2, 2026
Newsletter About
Business & Finance

J&J's first-quarter profit beats estimates even as Stelara sales disappoint

Strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more ​than offset a steep falloff in ​sales of its blockbuster ​autoimmune drug Stelara.

This article was originally published by CNBC Top News and is republished here under license.

Strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more ​than offset a steep falloff in ​sales of its blockbuster ​autoimmune drug Stelara.

More in Business & Finance

View All →

Leave a Reply

Discover more from The Meridian Review

Subscribe now to keep reading and get access to the full archive.

Continue reading